Managing Editor’s Memo
Frank Diamond
Legislation & Regulation
Richard Mark Kirkner
Contractor has challenges to overcome in turning a dead parrot into a phoenix.
Value-Based Tools
Michael D. Dalzell
Three quarters of the original ACOs that remain in the MSSP are still in Track 1. The Trump administration is tired of waiting for them to take on two-sided risk.
Medication Management
Thomas Reinke
Next month, the Sanofi and Regeneron product is expected to become the fourth monoclonal antibody approved as a treatment for severe asthma.
François de Brantes
Public opposition would be unseemly, so insurers and hospitals work behind the scenes against price transparency.
Laurie Golemi Norman, MSN, APRN
For organizations with a good strategy to reduce care variation, a hospital efficiency improvement program can provide the jolt of incentive that generates real improvement.
Maggie Alston
Bruce Pyenson
Pharma is used to risk, but adoption of alternative payment models would mean learning to navigate shared risk with payers.
News & Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report